CTOs on the Move


 
League Inc. is reimagining employee health benefits, and is on a mission to empower people to live healthier, happier lives —every day.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.league.com
  • 661 University Avenue Suite 1220
    Toronto, ON CAN M5G1M1
  • Phone: 647.255.1084

Executives

Name Title Contact Details
Mark Finkle
VP of Engineering (Productivity & Developer Program) Profile

Similar Companies

Orbus Therapeutics

Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.

Witham Health Services

Witham Health Services is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Witham Health Services is based in Lebanon, IN. You can find more information on Witham Health Services at www.witham.org

Foghorn Therapeutics

More than 20,000 genes make us human. Genes control critical aspects of health and disease — but what controls our genes? Foghorn® Therapeutics ($FHTX) is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order. By manipulating this system with our unique Gene Traffic Control™ platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease. With Gene Traffic Control™ Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.

Biodex

Biodex Medical Systems, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Biodex Medical Systems, Inc. is based in Shirley, NY. You can find more information on Biodex Medical Systems, Inc. at www.biodex.com

ISM-Immune System Management

ISM-Immune System Management Inc. is a Ottawa, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.